Pulmonary Fibrosis Foundation
Public records show a registered, tax-exempt organization in good standing.
What it says it does
THE PULMONARY FIBROSIS FOUNDATION IS COMMITTED TO ACCELERATING RESEARCH, EMPOWERING OUR COMMUNITY, AND TRANSFORMING CARE SO THAT EVERYONE WITH PULMONARY FIBROSIS CAN LIVE A BETTER LIFE. OUR ULTIMATE GOAL IS TO FIND A CURE FOR PULMONARY FIBROSIS.
- Income
- $9.3 million
- Spending
- $7.4 million
- Spent on programs
- 67%
- Reserves
- 16.5 months of spending
- Largest source of income
- donations and private grants, 86%
- Employees
- 39
- Volunteers
- 4,833
- Highest pay
- $432,668, president & ceo
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Strong: 96 out of 100. Higher than 81% of charities in its peer group (diseases, $1m to $10m).
Reserves
35 of 35Spendable reserves would cover 16.5 months of spending.
Debt
16 of 20It owes 21% of what it owns.
Living within its means
15 of 15Income exceeded spending by 20% of income.
Income trend
15 of 15Income rose 12% on the year before.
Spending floor
15 of 1567% of spending went to programs and raising each dollar of donations cost 14 cents.
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Strong: 100 out of 100. Higher than 61% of charities in its peer group (diseases, $1m to $10m).
Independent board
25 of 2515 of 15 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
8 of 8Has a written whistleblower policy.
Record keeping policy
7 of 7Has a written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
Pay set independently
5 of 5Sets its chief executive's pay through independent review and comparison.
Independent check of accounts
15 of 15Its accounts were audited by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (5)
- $1.2 million spent. PFF REGISTRY: THE PFF REGISTRY PROGRAM RECORDED A TOTAL REVENUE OF $957,196, ENCOMPASSING CONTRIBUTIONS AND SPONSORSHIPS AMOUNTING TO $273,150 AND PROGRAM SERVICE REVENUE TOTALING $684,045. THIS INITIATIVE SERVES AS A COLLABORATIVE RESEARCH ENDEAVOR, UNITING VARIOUS STAKEHOLDERS SUCH AS PATIENTS, CAREGIVERS, FAMILY MEMBERS, HEALTHCARE PROVIDERS, AND RESEARCHERS WITH THE GOAL OF ADVANCING RESEARCH AND ENHANCING THE QUALITY OF LIFE FOR INDIVIDUALS AFFECTED BY PULMONARY FIBROSIS (PF) AND INTERSTITIAL LUNG DISEASE (ILD).THE GOALS OF THE REGISTRY INCLUDE:1. ESTABLISH A COMPREHENSIVE INFORMATION SOURCE TO ASSIST RESEARCHERS IN ADDRESSING DIAGNOSTIC, TREATMENT, AND POTENTIAL CURE-RELATED QUERIES.2. PROVIDE A DATASET ENABLING RESEARCHERS TO ENHANCE THE QUALITY OF CARE IN US-BASED MEDICAL PRACTICES.3. UTILIZE INFORMATION TO SUPPORT LEGISLATIVE AND ADVOCACY INITIATIVES.4. ENGAGE THE PF AND ILD COMMUNITIES.THE REGISTRY INCLUDES TWO DISTINCT REGISTRIES:1. THE PFF PATIENT REGISTRY GATHERED PHYSICIAN-REPORTED MEDICAL INFORMATION TWICE A YEAR FROM OVER 2000 PATIENTS RECEIVING CARE AT 42 PARTICIPATING PFF CARE CENTERS ACROSS THE UNITED STATES FROM 2016 TO 2022.2. THE PFF COMMUNITY REGISTRY LAUNCHED IN JULY 2022 AND RELIES ON SELF-REPORTED INFORMATION SUBMITTED BY PATIENTS, LUNG TRANSPLANT RECIPIENTS DIAGNOSED WITH PF OR ILD, AS WELL AS THEIR CAREGIVERS AND BIOLOGICAL FAMILY MEMBERS, NEARLY 3,000 INDIVIDUALS HAVE ENROLLED TO DATE.TOGETHER, THESE REGISTRIES COMPILE DATA IN AN ELECTRONIC DATABASE COVERING PATIENT DIAGNOSIS, MEDICAL HISTORY, TREATMENT, QUALITY OF LIFE, AS WELL AS MEDICAL AND FAMILY HISTORY FROM CAREGIVERS AND FAMILY MEMBERS. THE COLLECTED DATA ARE ANONYMIZED AND INDEPENDENTLY MANAGED BY A DATA COORDINATING CENTER. FURTHERMORE, THE PATIENT REGISTRY OBTAINED BLOOD SAMPLES WITH PATIENT CONSENT, WHICH WERE THEN ANONYMIZED AND INDEPENDENTLY MANAGED BY A MEDICAL SPECIMEN STORAGE FACILITY ASSOCIATED WITH THE DATA COORDINATING CENTER.CURRENTLY, OVER 60 RESEARCH PROJECTS HAVE BEEN COMPLETED OR ARE UNDERWAY USING CLINICAL DATA AND SOME UTILIZED BIOSAMPLES AND/OR HRCT SCANS FROM THE PATIENT REGISTRY. MOST OF THESE STUDIES ARE CLINICAL IN NATURE, BUT BASIC/TRANSLATIONAL PROJECTS AND PATIENT-CENTERED RESEARCH ALSO ARE WELL REPRESENTED.
- $822,067 spent. EDUCATION: TOTAL REVENUE RECOGNIZED FOR EDUCATIONAL PROGRAMS WAS $548,062.THE PULMONARY FIBROSIS FOUNDATION (PFF) IS COMMITTED TO PROVIDING QUALITY DISEASE EDUCATION TO THE PULMONARY FIBROSIS (PF) AND INTERSTITIAL LUNG DISEASE (ILD) COMMUNITY. THE PFF STRIVES TO PROVIDE PATIENTS, CAREGIVERS, FAMILY MEMBERS, AND HEALTHCARE PROVIDERS WITH THE RESOURCES NECESSARY TO MORE FULLY UNDERSTAND PF AND ITS IMPACT AS WELL AS PROVIDE PATIENTS WITH THE TOOLS NECESSARY TO LIVE WITH THE DISEASE AND IMPROVE THEIR QUALITY OF LIFE.THE PFF DISEASE EDUCATION WEBINAR SERIES HAS SERVED AS AN ESSENTIAL PROGRAM TO ADVANCE OUR MISSION OF EDUCATING THE PF AND ILD COMMUNITY. THE WEBINAR SERIES PROVIDES A FREE, CONVENIENT WAY FOR PATIENTS, CAREGIVERS, AND FAMILIES TO LEARN FROM AND CONNECT WITH PF SPECIALISTS ON A VARIETY OF IMPORTANT TOPICS. DURING FY24-25, THE PFF DISEASE EDUCATION WEBINAR SERIES INCLUDED EIGHT WEBINARS. THE PFF DISEASE EDUCATION WEBINAR SERIES TOPICS INCLUDED: LUNG TRANSPLANT, EXPOSURES, DIAGNOSIS, PULMONARY FUNCTION TESTS, NUTRITION, RESEARCH, AUTOIMMUNE DISEASES, AND MORE. THE PFF DISEASE EDUCATION WEBINAR SERIES HOSTED OVER 1,500 LIVE ATTENDEES. WEBINARS ARE RECORDED AND AVAILABLE FOR VIEWING ON BOTH THE PULMONARY FIBROSIS FOUNDATION WEBSITE AND YOUTUBE CHANNEL. WEBINARS FROM THE PFF DISEASE EDUCATION WEBINAR SERIES FROM THIS TIMEFRAME HAVE AMASSED OVER 10,000 VIEWS ON YOUTUBE ALONE. IN ADDITION TO THE PFF DISEASE EDUCATION WEBINAR SERIES, THE FOUNDATION HAS DEVELOPED A LIBRARY OF DISEASE EDUCATION MATERIALS FOR PULMONARY FIBROSIS PATIENTS, CAREGIVERS, FAMILY MEMBERS, AND FRIENDS. DURING FY24-25, THE PULMONARY FIBROSIS FOUNDATION DEVELOPED THE FOLLOWING MATERIALS: TRANSLATION OF "COMMON HEALTH RESEARCH TERMS: A GUIDE FOR PEOPLE LIVING WITH PULMONARY FIBROSIS" IN SPANISH, "LUNG BIOPSY FOR INTERSTITIAL LUNG DISEASE" FACT SHEET, "GRAPHIC ILLUSTRATION OF LIQUID OXYGEN", AND "RECURSOS DE FIBROSIS PULMONAR" RESOURCE PAGE OF ALL EDUCATIONAL MATERIALS TRANSLATED INTO SPANISH.
- $544,405 spent. CORPORATE PARTNERSHIPS:TOTAL REVENUE RECOGNIZED FOR CORPORATE PARTNERSHIPS WAS $1,136,558, WHICH INCLUDED CONTRIBUTIONS AND SPONSORSHIPS OF $285,000, IN ADDITION TO THE PROGRAM SERVICE REVENUE OF $848,845.THE PFF SEEKS SPONSORSHIPS TO SUPPORT ITS MISSION-DRIVEN ACTIVITIES FROM PATIENT-SERVICE AND EDUCATION TO RESEARCH INITIATIVES. DURING THIS FISCAL YEAR, THE PFF CORPORATE PARTNERSHIPS TEAM CONTINUED TO SECURE SPONSORSHIP FOR THE PFF SUMMIT, THE WORLD'S LARGEST CONFERENCE DEDICATED TO PULMONARY FIBROSIS (PF) AND INTERSTITIAL LUNG DISEASE (ILD) RESEARCH AND EDUCATION. THE TEAM ALSO BEGAN SECURING SUPPORT FOR SEPTEMBER'S PULMONARY FIBROSIS AWARENESS MONTH, THE PFF EDUCATION SYMPOSIUM-OUR VIRTUAL CONFERENCE FOR PATIENTS AND CAREGIVERS-ALONG WITH KEY PROGRAMS INCLUDING THE PFF CARE CENTER NETWORK, THE PFF SCHOLARS PROGRAM, THE PFF REGISTRY, THE PATIENT EDUCATION MATERIALS PROGRAM, THE PFF SUPPORT GROUP LEADERS NETWORK, THE PFF AMBASSADORS PROGRAM, AND THE PFF DISEASE EDUCATION WEBINAR SERIES.THE PFF FURTHER ADVANCED ITS WORK WITH THE PFF CORPORATE COMMITTEE, WHICH SERVES AS A COLLABORATIVE FORUM FOR INDUSTRY PARTNERS TO ENGAGE WITH THE FOUNDATION'S LEADERSHIP AND VOLUNTEER NETWORK AND TO SUPPORT SHARED LEARNING ACROSS THE PF COMMUNITY. THIS YEAR, THE PFF ALSO LAUNCHED THE CLINICAL TRIAL INNOVATION WEBINAR SERIES, CREATING ADDITIONAL OPPORTUNITIES FOR TRIAL SPONSORS TO HIGHLIGHT THEIR RESEARCH AND OFFERING THE PF AND ILD COMMUNITY ANOTHER AVENUE TO STAY INFORMED ABOUT EMERGING SCIENTIFIC AND CLINICAL DEVELOPMENTS.
- MARKETING:IN EARLY 2024, THE MARKETING TEAM TOOK ON A MAJOR RE-DESIGN OF THE PFF HOMEPAGE TO MAKE IT MORE WELCOMING TO NEWLY DIAGNOSED PATIENTS AND THEIR FAMILIES. COMPARED TO 2023, THE HOMEPAGE'S REDESIGN PROJECT RESULTED IN A 7.5% INCREASE IN VISITS, A 26% INCREASE IN PAGE VIEWS, AND A 16% INCREASE IN EVENTS (CLICKING A LINK, LOADING A PAGE, WATCHING A VIDEO, ETC.). THE MARKETING TEAM ALSO BEGAN TO PLACE A HEAVIER EMPHASIS ON EMAIL MARKETING. THROUGH EMAIL ALONE, THERE WERE 5,607 TOTAL CLICKS TO THE PFF HOMEPAGE. WE ALSO EARNED 12,192 NEW SUBSCRIBERS TO OUR EMAIL LIST, BRINGING OUR TOTAL CONTACT BASE TO 64,872. OF THOSE NEW SUBSCRIBERS, 2,300 JOINED DURING PFAM, WHICH WAS OUR HIGHEST MONTH FOR NEW SIGNUPS. OTHER MONTHS AVERAGED ANYWHERE FROM 600 NEW SIGNUPS TO 1,000. SOCIAL MEDIA WAS AN IMPACTFUL TOOL TO REACH CURRENT PATIENTS AND FAMILIES. FURTHER, SOCIAL MEDIA IS THE MOST POWERFUL TOOL TO REACH PATIENTS AND FAMILIES WHO DO NOT KNOW ABOUT THE PFF. DURING THE FISCAL YEAR, ADVERTISEMENTS ON SOCIAL MEDIA REACHED 574,984 ACCOUNTS. OUR CONTENT WAS VIEWED ON FACEBOOK AND INSTAGRAM MORE THAN 2,067,456 TIMES. FURTHER, THE ADS EARNED 45,121 CLICKS TO THE PFF WEBSITE. IN EARLY 2025, THE FOUNDATION LAUNCHED ITS 25-YEAR ANNIVERSARY CAMPAIGN, 25 YEARS TOGETHER: HONORING THE PAST, BUILDING ON THE PRESENT, INNOVATING FOR THE FUTURE. THIS CAMPAIGN BEGAN WITH A NEW LOGO THAT INCLUDES A MEMORIAL RIBBON. OUR COMMUNITY RESPONDED SO POSITIVELY TO THE RIBBON THAT THE MARKETING TEAM WILL CONTINUE TO USE IT FOR CAMPAIGNS MOVING FORWARD. SIGNIFICANT 25-YEAR ANNIVERSARY PROJECTS INCLUDED A VARIETY OF PROFESSIONALLY FILMED VIDEOS, A SPECIAL EDITION OF THE BREATHE BULLETIN, A 25-YEAR ANNIVERSARY THEME FOR PFAM, AND AN INTERACTIVE TIMELINE ON OUR WEBSITE. FINALLY, NINE PRESS RELEASES THROUGH THE FISCAL YEAR RESULTED IN 75,310 VIEWS THROUGHOUT VARIOUS ONLINE MEDIA OUTLETS. RESEARCH:THE PULMONARY FIBROSIS FOUNDATION (PFF) PLACES ENORMOUS IMPORTANCE ON CREATING AN ENVIRONMENT THAT WILL ASSIST IN THE DEVELOPMENT OF EFFECTIVE TREATMENTS FOR PULMONARY FIBROSIS (PF). IN ADDITION TO CREATING THE PFF PATIENT REGISTRY TO PROVIDE RESEARCHERS WITH DATA TO ADDRESS SPECIFIC RESEARCH QUESTIONS, WE ARE DIRECTLY FUNDING PF RESEARCH THROUGH THE PFF SCHOLARS PROGRAM, DEVELOPING LEGISLATIVE ADVOCACY EFFORTS, ENCOURAGING COLLABORATIVE RELATIONS BETWEEN INDUSTRY AND ACADEMIC RESEARCHERS, DELIVERING KEY COMMUNICATIONS TO PATIENTS, AND DEVELOPING SOLUTIONS TO BRIDGE EXISTING GAPS IN PF RESEARCH.THE PFF SCHOLARS PROGRAM SUPPORTS PROJECTS THAT OFFER A HIGH LIKELIHOOD OF IMPROVING THE UNDERSTANDING OF PF IN THE FOLLOWING RESEARCH AREAS: BASIC SCIENCE, TRANSLATIONAL, CLINICAL, EPIDEMIOLOGICAL, AND HEALTH SERVICES. THE GOAL OF THE PFF SCHOLARS PROGRAM IS TO SUPPORT EMERGING INVESTIGATORS TO ADVANCE RESEARCH THAT COULD TRANSLATE INTO SUCCESSFUL THERAPIES, WHILE ALSO ENABLING THESE PROMISING RESEARCHERS TO OBTAIN INDEPENDENT FUNDING AND CONTINUE THEIR CUTTING-EDGE RESEARCH. THE RESEARCH REVIEW COMMITTEE ADMINISTERS THE PEER-REVIEW PROCESS, WHICH IS COMPRISED OF 25 CREDIBLE EXPERTS FROM THE US AND CANADA. AFTER THEIR REVIEW AND RECOMMENDATIONS, THE PFF FUNDED FIVE GRANTS OF $100,000 EACH OVER A TWO-YEAR PERIOD IN THE 2025 CYCLE. THE PFF ALSO CONCLUDED A TWO-YEAR SPECIAL RESEARCH GRANT THAT WAS AWARDED TO TWO AWARDEES WHO FOCUSED THEIR RESEARCH ON FAMILIAL PULMONARY FIBROSIS. THE FAMILIAL PULMONARY FIBROSIS RESEARCH GRANT WAS FUNDED ENTIRELY THROUGH THE GENEROUS GIFT OF A DONOR FOR A TOTAL OF $500K. THE PFF ALSO CONSIDERS OTHER SMALLER GRANTS THAT FIT THE PARAMETERS OF THE RESEARCH GUIDELINES. PFF CARE CENTER NETWORK (CCN):THE PULMONARY FIBROSIS FOUNDATION (PFF) IS DEDICATED TO PROMOTING EARLIER RECOGNITION AND DIAGNOSIS OF PULMONARY FIBROSIS AND ENSURING THAT PATIENTS RECEIVE THE HIGHEST QUALITY HEALTHCARE. AS PART OF THAT COMMITMENT, SINCE 2013 THE PFF HAS WORKED WITH THE PF MEDICAL COMMUNITY TO ESTABLISH AND EXPAND THE PFF CARE CENTER NETWORK (CCN) TO 80 CARE CENTERS AND 6 CLINICAL ASSOCIATES WHERE PEOPLE WITH PF CAN FIND EXPERIENCED MEDICAL PROFESSIONALS WHO UNDERSTAND THEIR DISEASE AND SUPPORT SERVICES TO IMPROVE THE QUALITY OF THEIR LIVES. THE GOALS OF THE PFF CCN ARE TO DELIVER STATE OF THE ART, PATIENT-CENTERED CARE; TO DISSEMINATE EDUCATION TO SUPPORT OUR PATIENTS, CAREGIVERS AND PROVIDERS; TO GIVE VOICE TO THE NEEDS OF OUR COMMUNITY THROUGH ADVOCACY AND FUNDRAISING; AND TO ACCELERATE RESEARCH IN PF BOTH DIRECTLY AND THROUGH COLLABORATIONS AND NETWORKING. THE CCN BRINGS HEALTHCARE PROVIDERS TOGETHER TO ADDRESS GAPS IN CARE, RESEARCH AND EDUCATION IN PULMONARY FIBROSIS. IN FY24-25, THE PFF REDESIGNATED 64 OF THE FIRST CARE CENTERS OF THE CCN, COMPLETED THE FIRST YEAR OF THE CLINICAL ASSOCIATE PILOT PROGRAM, AND EXPANDED THE NURSE AND ALLIED HEALTH NETWORK TO 430 MEMBERS. ADDITIONALLY, PFF COLLABORATES WITH INDUSTRY PARTNERS TO REVIEW CLINICAL TRIAL PROTOCOLS, PARTICIPATE IN PATIENT ADVISORY BOARDS, SUPPORT PATIENT RECRUITMENT ACTIVITIES AND MARKET RESEARCH EFFORTS, AND CONTRIBUTE TO STUDIES THAT ANALYZE DATA FROM THE PFF REGISTRY.THE PFF HELPS FACILITATE THE PROGNOSTIC LUNG FIBROSIS CONSORTIUM (PROLIFIC), A QUARTERLY FORUM THAT BRINGS TOGETHER INDUSTRY LEADERS FOR PRE-COMPETITIVE COLLABORATION FOCUSED ON ADVANCING BIOMARKER QUALIFICATION IN PULMONARY FIBROSIS AND ACCELERATING THE DEVELOPMENT AND REGULATORY APPROVAL OF NEW THERAPIES.SUPPORT GROUPS:THE PFF SUPPORT GROUP LEADER NETWORK PROVIDES A FORUM FOR PF SUPPORT GROUP LEADERS TO CONNECT, EXCHANGE IDEAS, AND SHARE BEST PRACTICES. THE PFF'S SUPPORT GROUP LEADER NETWORK CONSISTS OF OVER 135 SUPPORT GROUPS ACROSS THE COUNTRY. THE PFF PROVIDES AN ONLINE PLATFORM FOR GROUPS TO MEET AND CONNECT WITH OTHERS ACROSS THE NATION. THE PFF PROVIDES PHONE-BASED VIRTUAL SUPPORT GROUPS FOR MEMBERS OF THE PF AND ILD COMMUNITY WHO EITHER DO NOT HAVE A LOCAL SUPPORT GROUP OR ARE LOOKING FOR ADDITIONAL SUPPORT BETWEEN THEIR OTHER MEETINGS. THERE ARE THREE GROUPS INCLUDING A GROUP FOR GENERAL DISEASE EDUCAT
- $2.3 million spent. OUTREACH AND AWARENESS:THE PFF AMBASSADOR PROGRAM EMPOWERS PATIENTS, CAREGIVERS, LUNG TRANSPLANT RECIPIENTS, FAMILY MEMBERS, AND THOSE WHO HAVE LOST A LOVED ONE TO SERVE AS SPOKESPEOPLE FOR THE PF AND ILD COMMUNITY. COMPRISING A DIVERSE AND DYNAMIC GROUP OF VOLUNTEERS FROM ACROSS THE UNITED STATES, PFF AMBASSADORS UNDERGO FORMAL TRAINING TO PREPARE FOR SPEAKING AND ADVOCATING ON BEHALF OF THE PULMONARY FIBROSIS FOUNDATION AND THE PULMONARY FIBROSIS COMMUNITY. PFF AMBASSADORS REPRESENT THE FOUNDATION AS THEY ATTEND EVENTS VIRTUALLY AND IN-PERSON AROUND THE COUNTRY. EVENTS INCLUDE PFF CARE CENTER NETWORK EVENTS, SUPPORT GROUP MEETINGS, EDUCATION EVENTS, FUNDRAISERS, OTHER DISEASE AWARENESS AND EDUCATION PROGRAMS, AND A VARIETY OF MEDIA OPPORTUNITIES. PFF AMBASSADORS PROMOTE DISEASE AWARENESS, PROVIDE UP-TO-DATE INFORMATION, AND OFFER HOPE AND INSPIRATION TO THOSE AFFECTED BY PULMONARY FIBROSIS. IN JUNE 2025, THE PFF WELCOMED 15 NEW PFF AMBASSADORS TO THE PROGRAM. THIS BROUGHT THE PFF'S TOTAL NUMBER OF CURRENT PFF AMBASSADORS TO 52 INDIVIDUALS. THE PFF PROVIDES MONTHLY TRAINING TO PFF AMBASSADORS THROUGHOUT THE YEAR. IN NOVEMBER 2024, THE PFF HOSTED A VIRTUAL MEETING ONLINE FOR VOLUNTEERS, INCLUDING SUPPORT GROUP LEADERS, PFF AMBASSADORS, AND PFF ADVOCATES TO RECEIVE UP-TO-DATE INFORMATION ON THE FOUNDATION, RESOURCES AVAILABLE, AND TRAINING FOR THEIR ROLES.
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending June 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since November 2000.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.